UNSPSC 51143221: Nicotine tartrate

This classification denotes a nicotinic agonist and alkaloid with the molecular formula C10H14N2.2C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7892ZN5G41, chemically known as pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (s)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:2) (9ci) but more generally known as nicotine tartrate, which bears US NIH Compound Identifier 6174. European Medicines Agency schedules Nicotine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22391.

Most nations, for tariff and trade purposes, schedule nicotine tartrate under HS 29399990. SMILES: CN1CCC[C@H]1C2CCCNC2.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51143221 Nicotine tartrate is a Commodity code that shows minimal alignment with actual state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and safe drug deactivation systems, products that fall outside the nicotine-tartrate scope entirely. The mismatch suggests either a tagging error in the county's e-Procurement Portal or that the code is not actively used to classify pharmaceutical or medical-supply procurement at the state and local level.

Seminole County's June 2026 IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023. The procurement required electronic submission, included drug-free workplace and E-Verify compliance, and carried a two-year initial term with a one-year renewal option. The code shows no broader geographic activity or repeat issuing bodies in recent solicitations, limiting visibility into meaningful state and local market demand under the nicotine-tartrate classification.